Membrane ballooning in platelets during the blood-clotting process is driven by a coordinated system of salt and water entry which may be modified pharmacologically, a new study from the University of Bristol has found. The ...
Sep 2, 2015
0
32
Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events in older patients with atrial fibrillation who had a heart attack treated with angioplasty, and triple therapy resulted ...
Aug 3, 2015
0
6
Researchers conducted a prospective observational study in elderly patients and adult patients receiving antiplatelet therapy who presented with mild head injury at two trauma hospitals in Vienna: the Trauma Hospital Meidling ...
Jul 7, 2015
0
6
Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying reason for the variability ...
Apr 1, 2015
0
3
(HealthDay)—For patients with ischemic heart disease, responses to antiplatelet therapy (APT) vary between pre-discharge and one week after discharge from hospital, according to a study published online March 21 in the ...
Mar 30, 2015
0
2
An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse ...
Mar 17, 2015
0
8
(HealthDay)—Selective serotonin reuptake inhibitor (SSRI) use is associated with increased risk of upper gastrointestinal bleeding (UGIB), according to a meta-analysis published in the January issue of Clinical Gastroenterology ...
Jan 5, 2015
0
12
Victoria University of Wellington research has identified reasons why a significant portion of heart attack patients do not respond to commonly used treatments.
Dec 8, 2014
0
0
(HealthDay)—Perioperative planning is needed for decisions of timing of anticoagulation therapy in patients undergoing urological procedures, according to a review published in the October issue of The Journal of Urology.
Oct 10, 2014
0
0
A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration ...
Oct 31, 2013
0
0
